Periodic fever and erythema nodosum associated with MDS with trisomy 8: report of two cases and review of the literature

References

• Shimizu T, Ehrlich GE, Inaba G, Hayashi K. Behcet disease. Semin Arthritis Rheum. 1979;8:223–60.
   PubMed Web of Science ®Google Scholar
• Lee DS, Kim SH, Seo EJ, Park CJ, Chi HS, Ko EK, et al. Predominance of trisomy lq in myelodysplastic syndromes in Korean: is there an ethnic difference? A 3-year multi-center study. Cancer Genet Cytogenet. 2002;132:97–101.
   PubMedGoogle Scholar
• Voulgarelis M, Giannouli S, Ritis K, Tzioufas AG. Myelodus-plasia-associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Investig. 2004;34:690–700.
   PubMed Web of Science ®Google Scholar
• Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelo-dysplastic syndromes: response to immunosuppressive therapy. Br J Haematol. 1995;91:403–8.
   PubMed Web of Science ®Google Scholar
• Castro M, Conn DL, Su WP, Garton JP. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol. 1991;18:721–7.
   PubMed Web of Science ®Google Scholar
• Billstrom R, Johansson H, Johansson B, Mitelman F. Immune-mediated complications in patients with myelodysplastic syn-dromes-clinical and cytogenic features. Eur J Haematol. 1995;55:42–8.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Okada M, Mori A, Saheki K, Takatsuka H, Wada H, et al. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol. 1997;66:345–51.
   PubMed Web of Science ®Google Scholar
• Giannouli S, Voulgarelis M, Zintzaras E, Tzioufas AG, Mout-sopoulos HM. Autoimmune phenomena in myelodysplastic syn-dromes: a 4-yr prospective study. Rheumatology (Oxford). 2004;43: 626–32.
   Google Scholar
• Choi JH, Ahn MJ, Park YW, Oh HS, Lee YY, Kim IS. A case of erythema nodosum and serositis associated with myelodysplastic syndrome. Korean J Intern Med. 2005;20:177–9.
   PubMedGoogle Scholar
• Nehashi Y, Toni Y, Yaguchi M, Ito Y, Oyashiki K, Toyama K. Incomplete-form of Behcet disease in a case of monopathic myelodysplastic syndrome presenting as a thrombocytopenia (in Japanese). Rinsho Ketsueki. 1988;29:1097–102.
   PubMedGoogle Scholar
• Nakayama S, Ishikawa T, Yabe H, Nagai K. Refractory anemia complicated by Behcet's disease-report of three cases (in Japanese). Rinsho Ketsueki. 1989;30:530–4.
   PubMedGoogle Scholar
• Chyuma Y, Utsunomiya A, Saito T, Hanada S, Nishimata H, Arima M. Hemolytic anemia complicated with Behcet's disease and myelodysplastic syndrome (in Japanese). Rinsho Ketsueki. 1992;33:333–7.
   PubMedGoogle Scholar
• Yano K, Eguchi K, Migita K, Takashima H, Tamura M, Izumino K, et al. Behcet's disease complicated with myelodysplastic syn-drome: a report of two cases and review of the literature. Clin Rheumatol. 1996;15:91–3.
   PubMed Web of Science ®Google Scholar
• Yano K, Eguchi K, Takashima H, Ida H, Masahiro S, Hironori S, et al. Case of myelodysplastic syndrome associated with Behcet's disease (in Japanese). Nippon Naika Gakkai Zasshi. 1995;84:614–6.
   PubMedGoogle Scholar
• Ohno E, Ohtsuka E, Watanabe K, Kohno T, Takeoka K, Saburi Y, et al. Behcet's disease associated with myelodysplastic syndromes. A case report and a review of the literature. Cancer. 1997;79:262–8.
   Google Scholar
• Della Rossa A, Tavoni A, Tognetti A, Testi C, Bombardieri S. Behcet's disease with gastrointestinal involvement associated with myelodysplasia in a patient with congenital panhypopitui-tarism. Clin Rheumatol. 1998;17:515–7.
   Google Scholar
• Nawata R, Shinohara K, Takahashi T, Yamada T, Kagetsu K. Refractory anemia with trisomy-8 complicated by Behcet's disease with elevated levels of inflammatory cytokines (in Japanese). Rinsho Ketsueki. 1999;40: 1100–4.
   Google Scholar
• Tanaka E, Nishinarita M, Uesato M, Kamatani N. A case of intestinal Behcet's disease with abnormal ossification complicated by myelodysplastic syndrome, symptoms revealed after the per-foration of ileum ulcer (in Japanese). Ryumachi. 2000;40:711–8.
   PubMedGoogle Scholar
• Ogawa H, Kuroda T, Inada M, Yamamoto M, Enomoto H, Kishima Y, et al. Intestinal Behcet's disease associated with myelodysplastic syndrome with chromosomal trisomy 8-a report of two cases and review of the literature. Hepatogastro-enterology. 2001;48:416–20.
   PubMedGoogle Scholar
• Kimura S, Kuroda J, Akaogi T, Hayashi H, Kobayashi Y, Kondo M. Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis-Behcet's syndrome. Leuk Lymphoma. 2001;42:115–21.
   PubMed Web of Science ®Google Scholar
• Ito T, Otake K, Hosono O, Koide J, Takeuchi T, Abe T, et al. A case of RARS switching RAEB-T with myelofibrosis compli-cated with Behcet's disease (in Japanese). Rinsho Ketsueki. 1993;34:1288.
   Google Scholar
• Fujita H, Kiriyama M, Kawamura T, Ii T, Takegawa S, Dohba S, et al. Massive hemorrhage in a patient with intestinal Behcet's disease; report of a case. Surg Today. 2002;32:378–82.
   PubMedGoogle Scholar
• Adachi Y, Tsutsumi A, Murata H, Takemura H, Chino Y, Takahashi R, et al. Behcet's disease accompanied by myelodys-plastic syndrome with trisomy 8: two case reports and a review of 15 Japanese cases. Mod Rheumatol. 2003;13:90–4.
   PubMedGoogle Scholar
• Hasegawa H, Iwamasa K, Hatta N, Fujita S. Behcet's disease associated with myelodysplastic syndrome with elevated levels of inflammatory cytokines. Mod Rheumatol. 2003;13:350–5.
   PubMedGoogle Scholar
• Tomonari A, Tojo A, Takahashi T, Iseki T, Ooi J, Takahashi S, et al. Resolution of Behcet's disease after HLA-mismatched unrelated cord blood transplantation for melodysplastic syn-drome. Ann Hematol. 2004;83:464–6.
   PubMedGoogle Scholar
• Ando S, Maemori M, Sakai H, Ando S, Shiraishi H, Sakai K, et al. Constitutional trisomy 8 mosaicism with myelodysplastic syn-drome complicated by intestinal Behcet disease and antithrombin III deficiency. Cancer Genet Cytogenet. 2005;162:172–5.
   PubMedGoogle Scholar
• Kuttikat A, Haskard D, Chakravarty K. Behcet's disease associ-ated with trisomy 8 in a male Caucasian patient from Great Britain-a case report. Clin Exp Rheumatol. 2005;23:S108–9.
   Google Scholar
• Tsubata R, Suzuki F, Sugihara T, Ogawa J, Hagiyama H, Nanki T, et al. An autopsy case of intestinal Behcet's disease with sacroiliitis accompanied by myelodysplastic syndrome with trisomy 8 (in Japanese). Nihon Rinsho Meneki Gakkai Kaishi. 2005;28:48–55.
   PubMedGoogle Scholar
• Kawabata H, Sawaki T, Kawanami T, Shimoyama K, Karasawa H, Fukushima T, et al. Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Intern Med. 2006;45:1309–14.
   PubMed Web of Science ®Google Scholar
• Lin YC, Liang TH, Chang HN, Lin JS, Lin HY. Behcet's disease associated with myelodysplastic syndrome. J Clin Rheumatol. 2008;14:169–74.
   Google Scholar
• Ahn JK, Cha HS, Koh EM, Kim SH, Kim YG, Lee CK, et al. Behcet's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology. 2008;47:1228–30.
   PubMed Web of Science ®Google Scholar
• Chen G, Zeng W, Miyazato A, Billings E, Maciejewski JP, Kajigaya S, et al. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome character-ized by specific chromosomal abnormalities. Blood. 2004; 104:4210–8.
   PubMed Web of Science ®Google Scholar
• Touitou I, Kone-Paut I. Autoinflammatory diseases. Best Pract Res Clin Rheumatol. 2008;22:811–29.
   PubMed Web of Science ®Google Scholar
• Atagunduz P, Ergun T, Direskeneli H. MEFV mutations are increased in Behcet's disease and associated with vascular involvement. Clin Exp Rheumatol. 2003;21(Suppl 30):S35–7.
   Google Scholar
• Watanabe M, Ueno Y, Yajima T, Okamoto S, Hayashi T, Yamazaki M, et al. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med. 1998;187:389–402.
   PubMed Web of Science ®Google Scholar
• von Freeden-Jeffry U, Davidson N, Wiler R, Fort M, Burdach S, Murray R. IL-7 deficiency prevents development of a non-T cell non-B cell-mediated colitis. J Immunol. 1998;161: 5673–80.
   Google Scholar
• Galili N, Cerny J, Raza A. Current treatment options: impact of cytogenetics on the course of myelodysplasia. Curr Treat Options Oncol. 2007;8:117–28.
   PubMedGoogle Scholar